Trial Profile
Sleep-dependent Memory Processing in Schizophrenia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Eszopiclone (Primary)
- Indications Generalised anxiety disorder; Insomnia; Major depressive disorder
- Focus Pharmacodynamics
- 14 Apr 2017 Status changed from recruiting to completed.
- 24 Jul 2012 New trial record